Despite professional guidelines recommending early serious illness conversations for all patients with advanced cancer, many times these conversations occur, late or not at all. A collaborative research initiative at Dartmouth Cancer Center shows promise in improving patient–clinician communication by increasing the conduct and documentation of these important conversations in two medical oncology clinics.
Research
Geisel QBS Student Awarded Neukom Prize for Innovative Tumor Cell Project
Reflecting the strength of his interdisciplinary training, Ze Zhang, a PhD candidate in the Graduate Program in Quantitative Biomedical Sciences (QBS) and the Department of Epidemiology at Geisel, recently earned second prize for Outstanding Graduate Research in Computational Science in the Neukom Institute’s 2022 Research Awards.
Dartmouth Innovations for Cancer Accelerator Fosters Potentially Life-Saving Innovations
Thirty-five Dartmouth teams have participated in the accelerator over the past two years. Their research could save and prolong patients’ lives, and may even cure cancer.
Dartmouth’s Geisel School of Medicine Team Finds Increased Rate of TB Infection Among Adolescents in Tanzania
Findings from a new study published in PLOS ONE, led by investigators at Dartmouth’s Geisel School of Medicine and Muhimibili University of Health and Allied Sciences, show high rates of new tuberculosis (TB) infection among adolescents in Tanzania—highlighting the importance of developing TB control measures for this high-risk age group.
Armin Tavakkoli ’24 Receives Alpha Omega Alpha Fellowship
Geisel second-year MD student Armin Tavakkoli has been awarded a 2022 AOA Carolyn L. Kuckein Student Research Fellowship, which will support his research project to evaluate the therapeutic potential of FLASH radiation therapy in treatment of certain types of brain tumors.
Presenting the Best Evidence About a Controversial New Alzheimer’s Drug: Q & A with Dr. Steven Woloshin
Steven Woloshin, MD, MS, a professor of medicine and community and family medicine, and co-director of the Master of Health Care Delivery Science program at The Dartmouth Institute for Health Policy and Clinical Practice, discusses the controversy surrounding the FDA’s approval of Aducanumab—a new drug to treat mild Alzheimer disease.
Geisel Researchers Receive $4 Million Grant to Improve Office Visit Interactions Between People Living with Dementia, Care Partners, and Clinicians
A team of researchers at Dartmouth’s Geisel School of Medicine and New York University (NYU) Grossman School of Medicine has received a $4 million grant from the National Institute on Aging to improve “triadic” interactions between patients living with dementia, their care partners, and their clinicians.
Measuring Effectiveness of Clinician-led Innovation
Rebekah Davis, MPH ’22, put into practice the qualitative research skills she learned while pursuing her degree to evaluate the lasting effect of a program centered on clinician-led innovation.
Jason McLellan to Receive Inaugural McGuire Prize
Creator of breakthrough coronavirus technology will be awarded $100,000 at Dartmouth on May 13.
Detecting Potential Medication Side Effects in Treating Depression and Anxiety
A team of Geisel researchers find those treated with antidepressants exhibit a lower level of physical activity.